These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15853216)

  • 1. [Dose response curve of paclitaxel measured by histoculture drug response assay].
    Yoshimasu T; Oura S; Hirai I; Kokawa Y; Okamura Y; Furukawa T
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):497-500. PubMed ID: 15853216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of dose-response curve for paclitaxel in breast cancer.
    Yoshimasu T; Oura S; Hirai I; Tamaki T; Kokawa Y; Ota F; Nakamura R; Shimizu Y; Kawago M; Hirai Y; Naito K; Kiyoi M; Tanino H; Okamura Y; Furukawa T
    Breast Cancer; 2007; 14(4):401-5. PubMed ID: 17986806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial cancer cell lines are sensitive to paclitaxel.
    Rantanen V; Grénman S; Kulmala J; Grénman R
    Anticancer Res; 1996; 16(1):475-9. PubMed ID: 8615657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of the histoculture drug response assay (HDRA) based perioperative chemotherapy for non-small cell lung cancer].
    Tanahashi M; Yamada T; Moriyama S; Suzuki E; Niwa H
    Kyobu Geka; 2008 Jan; 61(1):26-30. PubMed ID: 18186269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histoculture drug response assay guided concurrent chemoradiotherapy for non-small cell lung cancer].
    Tamaki T; Oura S; Yoshimasu T; Ota F; Nakamura R; Shimizu Y; Kiyoi M; Naito K; Hirai Y; Okamura Y
    Kyobu Geka; 2008 Jan; 61(1):31-5. PubMed ID: 18186270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulvar squamous cell carcinoma cell lines are sensitive to paclitaxel in vitro.
    Jaakkola M; Rantanen V; Grénman S; Kulmala J; Grénman R
    Anticancer Res; 1997; 17(2A):939-43. PubMed ID: 9137431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC).
    Cohen RB; Langer CJ; Simon GR; Eisenberg PD; Hainsworth JD; Madajewicz S; Cosgriff TM; Pierce K; Xu H; Liau K; Healey D
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):81-9. PubMed ID: 17031646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.
    Lu S; Zhang J; Zhou Z; Liao ML; He WZ; Zhou XY; Li ZM; Xiang JQ; Wang JJ; Chen HQ
    Oncol Rep; 2008 Sep; 20(3):581-7. PubMed ID: 18695909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.
    Hermann TW; Yen WC; Tooker P; Fan B; Roegner K; Negro-Vilar A; Lamph WW; Bissonnette RP
    Lung Cancer; 2005 Oct; 50(1):9-18. PubMed ID: 15993980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
    Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cut-off level of docetaxel, paclitaxel and gemcitabine in histoculture drug response assay for non-small cell lung cancer].
    Yoshimasu T; Oura S; Hirai I; Kokawa Y; Hata K; Kawago M; Tanino H; Okamura Y; Furukawa T
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):1013-6. PubMed ID: 16044964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Technetium-99m labeled synaptotagmin I C2A detection of paclitaxel-induced apoptosis in non-small cell lung cancer].
    Wang F; Fang W; Ji SD; Meng QL; Li Y; Fan KW; Wang ZZ
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):351-4. PubMed ID: 17892130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel and vincristine potentiate adenoviral oncolysis that is associated with cell cycle and apoptosis modulation, whereas they differentially affect the viral life cycle in non-small-cell lung cancer cells.
    AbouEl Hassan MA; Braam SR; Kruyt FA
    Cancer Gene Ther; 2006 Dec; 13(12):1105-14. PubMed ID: 16841078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combretastatin A-4 resistance in H460 human lung carcinoma demonstrates distinctive alterations in beta-tubulin isotype expression.
    Wehbe H; Kearney CM; Pinney KG
    Anticancer Res; 2005; 25(6B):3865-70. PubMed ID: 16309172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferating activity of the mitotic inhibitor pironetin against vindesine- and paclitaxel-resistant human small cell lung cancer H69 cells.
    Yoshida M; Matsui Y; Ikarashi Y; Usui T; Osada H; Wakasugi H
    Anticancer Res; 2007; 27(2):729-36. PubMed ID: 17465195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of local tumor growth with paclitaxel-loaded microspheres.
    Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
    Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
    Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thoracic radiation therapy and concomitant low-dose daily paclitaxel in non-small cell lung cancer: a phase I study.
    Gobitti C; Franchin G; Minatel E; Gigante M; Basso B; Bujor L; Trovò MG
    Oncol Rep; 2005 Dec; 14(6):1647-53. PubMed ID: 16273271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-cytotoxic and sublethal paclitaxel treatment potentiates the sensitivity of cultured ovarian tumor SKOV-3 cells to lysis by lymphokine-activated killer cells.
    Law KS; Chen HC; Liao SK
    Anticancer Res; 2007; 27(2):841-50. PubMed ID: 17465210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of biweekly paclitaxel and carboplatin for frail patients with advanced non-small cell lung cancer.
    Yanagitani N; Tsuchiya S; Kaira K; Sunaga N; Tsuchiya Y; Sato K; Watanabe S; Nomura S; Sakai S; Saito R; Mori M
    Am J Clin Oncol; 2007 Oct; 30(5):487-91. PubMed ID: 17921708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.